Influential IOF scientific journals now with higher impact factors

5756
Newly announced 2014 impact factors: Calcified Tissue International & Musculoskeletal Research’s impact factor increases by 19%, Osteoporosis International five year impact factor now 4.242.

The Thomas Reuters Science Citation Index (SCI) has recently announced the 2014 impact factors of more than 6500 leading peer-reviewed science and technology journals. 
With an increase in their impact factors, IOF’s key peer reviewed journals remain among the most oft-cited within the musculoskeletal field and continue to rank highly within the broader league of endocrinology journals.

Calcified Tissue International & Musculoskeletal Research

This key journal, focused on preclinical, translational and clinical research in the bone and muscle field. has made a significant leap forward (19%) since 2013 with a new impact factor of 3.272. The journal now ranks 55 out of 128 in the SCI Endocrinology category. 

Prof. Cyrus Cooper, Chair of the IOF Committee of Scientific Advisors, said,

We’re very pleased that Calcified Tissue International is among the most oft cited journals dealing with original preclinical, translational and clinical research in the bone and muscle field. The significant increase in the journal’s impact factor for 2014 is wonderful news. It is testimony to the dedication of the distinguished Co-editors, Stuart Ralston and René Rizzoli, as well as to the new muscular research focus, a section headed by leading investigator Roger Fielding.”

Calcified Tissue International has published recent special review issues with a focus on Vitamin D, skeletal muscle in health and disease, and bone material properties

Osteoporosis International

Ranked 33 out of 128 journals in the endocrinology field, Osteoporosis International is a key forum for clinical research in the field of osteoporosis and related musculoskeletal diseases. Osteoporosis International’s newly announced five-year impact factor is 4.242 (2014 impact factor: 4.169). Prof. John Kanis, Co-Editor-in-Chief of Osteoporosis International stated,

We’re pleased that the journal’s impact factor is on the increase and that it has established itself as a leading publication for high-quality clinically-focused research. I join our dedicated editorial team in encouraging submissions of the latest research dealing with all aspects of osteoporosis, bone disease, and muscle research including in the areas of frailty and sarcopenia.”

Calcified Tissue International and Musculoskeletal Research

This peer-reviewed journal publishes original preclinical, translational and clinical research, and reviews concerning the structure and function of bone, and other musculoskeletal tissues in living organisms, as well as clinical studies of musculoskeletal disease. It includes studies of cell biology, molecular biology, intracellular signaling, and physiology, as well as research into the hormones, cytokines and other mediators that influence the musculoskeletal system. The journal also publishes clinical studies of relevance to bone disease, mineral metabolism, muscle function, and musculoskeletal interactions. 2014 Impact Factor: 3.272
Submit a paper

Editors-in-Chief: Stuart Ralston, René Rizzoli;
Musculoskeletal Research Section Editor: Roger Fielding

Osteoporosis International

Osteoporosis International is a joint initiative of IOF and the National Osteoporosis Foundation (USA). The journal provides an interdisciplinary platform for the communication of high quality original, experimental or clinical papers on all aspects of osteoporosis and other metabolic bone diseases. It also publishes studies pertaining to the diagnosis, prevention, treatment and management of osteoporosis, and the spectrum of disorders that deficiencies in bone density can produce. 2014 Impact Factor: 4.169
Editors-in-Chief:  Robert Lindsay; John Kanis

> Get free or low-cost access to IOF scientific journals via the IOF website (sign in or become a member)